Lack of modifying effects of prepubertal exposure to acrylamide (AA) on N-methyl-N-nitrosourea (MNU)-induced multi-organ carcinogenesis in F344 rats. 2010

Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
Division of Pathology, National Institute of Health Sciences, Tokyo. takamis@nihs.go.jp

Acrylamide (AA) has been reported to be formed in fried and baked foods with various concentrations, and exposure levels to AA from cooked foods in children are estimated to be higher than those in adults. In order to evaluate the carcinogenicity of AA exposure during childhood, we conducted a medium-term carcinogenicity study with prepubertal administration of AA followed by treatments of a multi-organ-targeted genotoxic carcinogen and a promoting agent for thyroid carcinogenesis in rats. A total of 36 postpartum F344 rats were given drinking water containing AA at 0, 20, 40 or 80 ppm for 3 weeks during the lactation period, and their weaned offspring received the same AA-containing water for 3 more weeks. Offspring were then injected with N-methyl-N-nitrosourea (MNU; 40 mg/kg body weight, i.p.) once at week 7 after birth. Half the animals of the 0 and 40 ppm groups were additionally treated with the anti-thyroid agent sulfadimethoxine (SDM; 125 ppm) in the drinking water thereafter. Offspring were subjected to complete necropsy at week 50. All the major organs and macroscopic abnormalities were excised and examined histopathologically. There was no significant difference in the incidences of hyperplastic and neoplastic lesions in the target organs of AA and/or MNU, such as the brain, spinal cord, pituitary gland, thyroid, adrenal glands, uterus, mammary glands, clitoral gland and tunica vaginalis. In conclusion, no significant modifying actions of AA on MNU-induced multi-organ carcinogenesis were exhibited in any organs of rats when exposed prepubertally under the present experimental conditions.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007774 Lactation The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN. Lactation, Prolonged,Milk Secretion,Lactations, Prolonged,Milk Secretions,Prolonged Lactation,Prolonged Lactations
D008297 Male Males
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003043 Cocarcinogenesis The combination of two or more different factors in the production of cancer. Cocarcinogeneses
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females

Related Publications

Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
August 1989, The Journal of toxicological sciences,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
January 1993, Japanese journal of cancer research : Gann,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
February 1993, Japanese journal of cancer research : Gann,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
January 1981, Experimental pathology,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
January 1988, Journal of cancer research and clinical oncology,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
December 1999, The Journal of toxicological sciences,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
January 1985, Journal of cancer research and clinical oncology,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
March 2003, Cancer science,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
January 2002, IARC scientific publications,
Shigeaki Takami, and Toshio Imai, and Young-Man Cho, and Masao Hirose, and Akiyoshi Nishikawa
December 2003, Cancer letters,
Copied contents to your clipboard!